Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tommysdad who wrote (3483)	12/30/1997 8:56:00 PM
From: JOHN W.	of 6136

<<What is your source of information that Viracept has been tested in combination with Sustiva? Who would sponsor such a trial? It's against DuPont-Merck's interest.>> This was the first mention I can find that relates DMP-266 with Nelf. If you read the link, it will show that not only has the study has been done despite your previous statement, but was the first of many positive indications with Nelf\Sustiva. Quite Ironic that Nelfinavir appears to work better with Sustiva than Crix (not just the change in levels of the drugs). I laso have a few analyst notes that mention this. Also, call Agouron. thebody.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next